INKON Life Technology Co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Yingkang Life Technology Co., Ltd. was established in 1998 and listed on the Shenzhen Stock Exchange Growth Enterprise Board in December 2010. In March 2019, the actual controller was changed to Haier Group Company. The company has a vision of "a lifetime of health for all" and, after 20 years of transformation and development, has gradually grown into a leading comprehensive service provider for tumor radiation therapy equipment and tumor medical service operator in China. In recent years, the company has focused on the global leading construction of the IoT medical technology ecosystem, with patients as the center, adhering to the concept of doctor-patient integration, focusing on the entire tumor industry chain, relying on the integrated development of the experience network (medical service end) and the AIOT network (artificial intelligence IoT medical device end), starting from user pain points, to create an ecological brand of the tumor full chain pre diagnosis and health intelligent platform, Committed to reducing the scissors gap between China's average life expectancy and healthy life expectancy in the cause of national health, improving the quality of life for cancer patients, and ensuring lifelong well-being for all. At present, the company has three hospitals under its umbrella, namely Sichuan Friendship Hospital, Suzhou Guangci Tumor Hospital, and Chongqing Huajian Youfang Hospital. It also manages Yuncheng First Hospital, Changchun Yingkang Hospital, and Shanghai Yongci Rehabilitation Hospital, including one tertiary first-class hospital, one tertiary specialized hospital, and one tertiary comprehensive hospital each. In the future, the company will continue to adhere to the vision of "a lifetime of health for all", focusing on the technology ecological strategy positioning of tumor pre diagnosis, treatment, and health scenarios, focusing on the best user experience. From tumor scenarios, rehabilitation care scenarios, and health management scenarios, the company will build a full course and full cycle disease treatment and health management system, committed to serving a patient and moving a family. Tumor pre diagnosis and treatment health "experience network": relying on "service" contacts, create a full life and full cycle experience center. Focus on the H2H (HospitaltoHome) strategy and build a collaborative ecosystem of user experience iteration. Focusing on the seamless experience of users in the front, middle, and back, we aim to ensure that users stay online while away from the hospital, continuously enhancing the competitiveness of the tumor pre diagnosis and treatment health model. Tumor pre diagnosis and treatment health "AIOT network": relying on "device" contacts to create AIOT solutions. Insight into new opportunities for industry transformation and development, based on changes in the environment and user needs, actively layout forward looking technology directions, and actively explore from tumor treatment to rehabilitation and diagnosis fields. |
| Headquarter | Qingdao |
| Establish Date | 8/6/1998 |
| Listed Code | 300143.SZ |
| Listed Date | 12/9/2010 |
| Chairman | Tan Lixia. |
| CEO | Peng Wen. |
| Website | www.inkonlife.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
